| 1 |
32807688 | Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2. | 2021 Feb |
1 |
| 2 |
27095759 | [Association between ribavirin plasma concentration and sustained virologic response in treatment of patients with genotype 1b chronic hepatitis C with pegylated interferon-α-2b and ribavirin]. | 2016 Mar 20 |
3 |
| 3 |
27206440 | Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C. | 2016 May 25 |
1 |
| 4 |
24488144 | Drug resistance of a viral population and its individual intrahost variants during the first 48 hours of therapy. | 2014 Jun |
1 |
| 5 |
25173222 | [Short-term curative effect of ribavirin combination therapy with pegylated interferon alfa-2a vs. interferon alfa-2a in patients with chronic hepatitis C]. | 2014 Apr |
1 |
| 6 |
25757280 | [Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro]. | 2014 Nov |
6 |
| 7 |
23650781 | Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon. | 2013 Mar |
1 |
| 8 |
21932410 | Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias? | 2012 Jan |
1 |
| 9 |
22126968 | Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C. | 2012 Jan |
1 |
| 10 |
22154462 | Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus. | 2012 Mar |
1 |
| 11 |
22396433 | Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV. | 2012 Jun |
1 |
| 12 |
22450877 | An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. | 2012 Oct |
1 |
| 13 |
22475143 | [Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin]. | 2012 Mar |
1 |
| 14 |
23289278 | [Antiviral/immunomodulatory combination therapy: pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection]. | 2012 Sep-Oct |
1 |
| 15 |
21393126 | Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response. | 2011 May |
2 |
| 16 |
21951389 | Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus. | 2011 Dec |
1 |
| 17 |
20104263 | Retinol supplements antiviral action of interferon in patients with chronic hepatitis C: a prospective pilot study. | 2010 Jan |
1 |
| 18 |
20713999 | Chronic hepatitis C treatment in näive patients. | 2010 |
3 |
| 19 |
19375037 | [ANRS HC 02 RIBAVIC: histo-pathological impact]. | 2009 Mar |
1 |
| 20 |
19552663 | Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin. | 2009 Aug |
1 |
| 21 |
19581773 | Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C. | 2009 Jun |
1 |
| 22 |
20191195 | Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil. | 2009 Jun |
1 |
| 23 |
18081733 | Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C. | 2008 Mar 1 |
1 |
| 24 |
18248380 | Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C. | 2008 Aug |
1 |
| 25 |
19198574 | Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection. | 2008 Jul-Sep |
1 |
| 26 |
16004522 | Treatment with pegylated interferon alpha-2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin. | 2005 May |
1 |
| 27 |
16060397 | Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. | 2005 |
1 |
| 28 |
14974875 | Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C. | 2004 |
1 |
| 29 |
15069622 | High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load. | 2004 |
1 |
| 30 |
15208476 | Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response. | 2004 |
1 |
| 31 |
15681898 | Assessment of adverse reactions and pharmacokinetics of ribavirin in combination with interferon alpha-2b in patients with chronic hepatitis C. | 2004 Dec |
1 |
| 32 |
12618532 | A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. | 2003 Mar-Apr |
2 |
| 33 |
12656650 | Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C. | 2003 |
1 |
| 34 |
12749244 | High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C. | 2003 Mar-Apr |
1 |
| 35 |
12757175 | Combination therapy with interferon-alpha(2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin. | 2003 Mar |
1 |
| 36 |
14633177 | Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C. | 2003 Nov |
1 |
| 37 |
11827565 | Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C. | 2002 |
1 |
| 38 |
12052714 | Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. | 2002 Jun 17 |
1 |
| 39 |
12643293 | Clinical comparison of high-dose interferon-alpha2b with or without ribavirin for treatment of interferon-relapsed chronic hepatitis C. | 2002 Dec |
3 |
| 40 |
11680575 | Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial. | 2001 Oct |
1 |
| 41 |
10192200 | Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. | 1999 Feb |
1 |
| 42 |
10460040 | Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. | 1999 Aug |
1 |
| 43 |
10607236 | Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C. | 1999 May |
1 |
| 44 |
9672184 | Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. | 1998 Jun |
1 |
| 45 |
9807989 | Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) | 1998 Oct 31 |
1 |
| 46 |
18020586 | Interferon-alpha-2a: a review of its use in chronic hepatitis C. | 1998 Jul |
1 |
| 47 |
6703684 | Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro. | 1984 Jan |
1 |